Candidates : Actualité Candidates en direct - P1 | Bourse Reflex
Accueil > Tags > Candidates

  • Toutes les actualités en rapport avec « Candidates »

02/05 07:30 Candidates - ORAL PRESENTATION OF THERANEXUS AT THE 9TH EUROPEAN CONGRESS ON NARCOLEPSY 5 AND 6 MAY IN MONTPELLIER

26/04 18:00 Candidates - THERANEXUS ANNOUNCES ITS 2017 ANNUAL RESULTS AND PRESENTS AN UPDATE ON THE PROGRESS OF ITS CLINICAL TRIALS

23/04 07:30 Candidates - THN102 OBTAINS INVESTIGATIONAL NEW DRUG STATUS FROM THE FOOD AND DRUG ADMINISTRATION (FDA)

19/04 18:00 Candidates - THERANEXUS ANNOUNCES THE FIRST EUROPEAN APPROVAL FOR ITS PHASE 2 CLINICAL TRIAL WITH THN 102 IN PARKINSON'S DISEASE PATIENTS

09/04 18:00 Candidates - Quantum Genomics strengthens its governance

21/03 07:30 Candidates - THERANEXUS ANNOUNCES A SUCCESSFUL CLINICAL PHARMACOKINETIC STUDY AS PART OF THE DEVELOPMENT OF ITS DRUG CANDIDATES THN201 AND THN101

15/03 07:30 Candidates - THERANEXUS AND THE COLLEGE DE FRANCE SIGN A RESEARCH AGREEMENT ON ASTROCYTE-NEURON INTERACTIONS

23/11 15:00 Candidates - ABEO wins the 5th European Small and Mid-Cap Awards 2017 in the "International Star" category

24/10 14:15 Candidates - WALLIX GROUP RECEIVES THE SECURITY AWARD OF THE CERCLE DE L'ENTREPRISE et DE L'INTÉRÊT GÉNÉRAL

28/09 07:30 Candidates - Theranexus files its registration document as part of its planned Initial Public Offering (IPO) on the Euronext Growth market in Paris

25/04 18:00 Candidates - Quantum Genomics appoints Bruno Besse as Chief Medical Officer

30/03 18:00 Candidates - 2016 annual financial results and next development steps in 2017

28/02 17:45 Candidates - Genticel becomes Genkyotex: Genticel's General Meeting approves the strategic combination with GenKyoTex SA

30/01 18:00 Candidates - BUSINESS UPDATE - FOURTH QUARTER 2016

03/01 18:00 Candidates - Disclosure of the total number of voting rights and shares composing the share capital

03/01 18:00 Candidates - SUMMARY OF GENTICEL'S LIQUIDITY CONTRACT WITH ODDO CORPORATE FINANCE

22/12 13:00 Candidates - Genticel and Genkyotex Announce Intention to Enter into Strategic Combination

13/12 18:30 Candidates - GENTICEL REPORTS FINAL RESULTS OF GTL001 PHASE 2 TRIAL IN HPV16/18-INFECTED WOMEN

30/11 08:00 Candidates - GENTICEL successfully completes determining milestone in partnership with Serum Institute regarding use of GTL003 in multivalent vaccines

27/10 18:35 Candidates - BUSINESS UPDATE - THIRD QUARTER 2016